Johnson & Johnson Earnings Preview: What to Expect

With a market cap of $352.5 billion, New Jersey-based Johnson & Johnson (JNJ) focuses on the healthcare sector. Renowned for its diversified approach, JNJ operates across pharmaceuticals, medical devices, and consumer products, touching lives globally. From the Americas to Europe, Asia, Africa, and Australia, this healthcare giant continually pushes boundaries, making strides in innovation and patient care. Johnson & Johnson is expected to announce its fiscal Q2 earnings before the markets open on Wednesday, July 17.

Ahead of the event, analysts expect Johnson & Johnson to report a profit of $2.73 per share, down 2.5% from $2.80 per share reported in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates over the past four quarters.